Feuille James sold $11.6M of CHYM (indirect holdings)

Feuille James sold 351,890 indirectly-held shares of Chime Financial, Inc. (CHYM) at an average of $33.00 ($32.89–$33.15, $11.61M total) across 3 trades over 2026-09-10 to 2026-09-11.

Original reporting
SEC EDGAR · Feuille James
Published Sep 14, 2026, 9:51 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 14, 2026, 9:55 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CHYM
Bearish
medium confidence
Mentioned
$CHYM
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CHYMBearishLow
01

Why it matters

The director's sale represents the first report of a material insider divestiture for CHYM this quarter.

02

Market read

First‑report insider sale of over $10M may influence short‑term price action and sentiment toward CHYM.

03

What to watch

Potential upcoming earnings or product news that could offset the negative signal.

Relevance 7/10Novelty 5/10Timing: Filed Sep 14 2026 (Form 4)

Background

SEC Form 4 filings provide the first public disclosure of insider transactions.

Company-level read

Ticker impact

$CHYMBearishMedium confidence
Context

Director Feuille James sold $11.6M of CHYM shares via open‑market trades on Sep 10‑11, 2026.

Expected impact

Short‑term downward pressure; traders may consider a modest sell or hedge.

Evidence & confidence

A $11.6M sale by a director is material but not extraordinary; market reaction typically modest.

Market effects

May raise concerns for fintech sector if other insiders follow suit.

Limited to U.S. markets where CHYM trades.

Minimal; impact confined to CHYM and possibly comparable digital‑bank stocks.

Counterpoint

The sale could be a routine liquidity move unrelated to company fundamentals.

Key entities

  • Feuille James

    Insider who sold 351,890 CHYM shares.

  • Chime Financial, Inc.

    Fintech lender listed on Nasdaq under ticker CHYM.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CHYMHigh

Why is Chime Financial stock climbing today?

Chime Financial (CHYM) stock rose 2.8% in pre-market trading ahead of its inclusion in the S&P MidCap 400 index. Analysts raised price targets, with an average recommendation of 'Buy'. Q3 revenue grew 32% to $718M, and guidance was increased. The stock's gain contrasts with broader market declines.

$CHYMMed

Wells Fargo raises Chime Financial price target on strong results

Wells Fargo raised its price target for Chime Financial (CHYM) to $42.00 from $39.00, citing strong Q3 results and improved 2026 guidance. The company's revenue grew 26% with an 89% gross profit margin, though it remains unprofitable with an EPS of -$0.05. Chime's stock has gained 56% over the past year, trading at $29.87 with a market cap of $11.31 billion. The firm expects the Stride acquisition to close in early 2027, generating $100 million in annual synergies.

$CHYMHighAI 8/10

B.Riley raises Chime Financial stock price target on strong results

B.Riley raised its price target on Chime Financial (NASDAQ:CHYM) to $45.00, citing strong Q3 2026 results. Revenue was $718M, adjusted EBITDA $137M, both exceeding estimates. The company reported GAAP profitability for the third straight quarter, with net income of $44M. Active members reached 10.9M, and management raised full-year guidance. CHYM stock is up 56% over the past year, trading at $29.87.